LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,059 | -22.7% | 6,009 | -7.0% | 0.01% | -20.0% |
| Q2 2023 | $465,982 | -2.0% | 6,463 | 0.0% | 0.01% | -9.1% |
| Q1 2023 | $475,418 | +7.3% | 6,463 | -2.5% | 0.01% | -15.4% |
| Q4 2022 | $442,951 | -27.4% | 6,631 | -3.0% | 0.01% | -35.0% |
| Q2 2022 | $610,000 | -19.1% | 6,835 | +2.0% | 0.02% | 0.0% |
| Q1 2022 | $754,000 | -26.7% | 6,702 | +0.6% | 0.02% | -25.9% |
| Q4 2021 | $1,029,000 | +11.6% | 6,662 | +1.5% | 0.03% | +3.8% |
| Q3 2021 | $922,000 | – | 6,562 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |